Purchase Order 36C24224P1202

This federal contract award was issued by the Veterans Integrated Service Network 2 (VISN 2), which is part of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 firm-fixed-price purchase order is for the delivery of transducer products and is not associated with a set-aside designation.

Novocure is the prime contractor and sole provider of the products and services under this contract. The company specializes in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology, which is FDA-approved for the treatment of glioblastoma and mesothelioma. This contract supports the VA's mission of expanding veterans' access to innovative cancer therapies by enabling VA medical centers to obtain Novocure's Optune TTFields devices, transducer arrays, rental equipment, and related support services.

The contract is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million and runs through October 2027. This FSS contract provides a streamlined procurement vehicle for the VA to efficiently acquire Novocure's cancer treatment technologies and services.